Pharmaceutics & Medical Products

Many companies’ efforts to do more with less have stalled. Six situations present opportunities for executives to reignite...

The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and...

Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires...

Emerging markets are becoming ever more important for pharma. Yet to be successful, a rapid shift from a marketing and sales...

Despite macroeconomic deceleration, we expect Brazil's pharma market to grow 7–10 percent per year until 2020. Double-digit...

Device manufacturers experiencing declining growth or narrowing margins may need to reevaluate their commercial models.

Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory...

Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving. ...

A decade of restructuring and transformation efforts has taken a toll on organizational health.

Global pharma companies are missing a chance to serve Brazil’s increasingly prosperous and growing middle class.